Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Novoheart Holdings Inc. V.NVH

Healthcare Biotechnology
"Novoheart Holdings Inc is a Canadian based company. It is engaged in the engineering bio-artificial human heart tissues and chambers for drug discovery, cardiotoxicity screening, disease modeling and future therapeutic applications. Novoheart's scientific team has pioneered a range of bioengineering technologies collectively known as the MyHeart platform, including first human mini-heart 'novoHeart' that is capable of fully capable of pumping and ejecting fluid."


TSXV:NVH - Post by User

Novoheart Holdings Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by Aberta1on Dec 08, 2017 10:56am
182 Views
Post# 27117390

Novoheart creates tiny heart-like structure with stem cells

Novoheart creates tiny heart-like structure with stem cells
Novoheart says it has pharmaceutical companies interested in its technology but securities regulations prevent the company from disclosing them until the proper paperwork is filed with the securities regulator.


https://www.cbc.ca/news/business/novoheart-stem-cells-tiny-hearts-drug-testing-1.4432367
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities